Extract blend inhibits E. coli adhesion
May 27, 2008
by Jeff Gelski
Cranforte, a cranberry and grape seed extract blend designed for functional foods and nutraceutical products, inhibited E. coli adhesion to human bladder cells by 37% at a low concentration, according to an in vitro study led by Dr. Zbigniew Pietrzkowski, the head of the research and development division for FutureCeuticals, Inc., Momence, Ill. The next closest cranberry product had an inhibition rate of 31% at the same concentration.
FutureCeuticals offers Cranforte, which provides Oligoremic Proanthocyanidins (OPC), which are compounds responsible for inhibiting adhesion of E. coli bacteria associated with urinary tract infections.
For more information, visit www.futureceuticals.com.
This article can also be found in the digital edition of Food Business News, May 27, 2008, starting on Page 65. Click
to search that archive.